TY - JOUR T1 - Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 3 LP - 4 DO - 10.1183/09059180.00008713 VL - 23 IS - 131 AU - Venerino Poletti Y1 - 2014/03/01 UR - http://err.ersjournals.com/content/23/131/3.abstract N2 - Idiopathic pulmonary fibrosis (IPF) is a rare but inevitably progressive and fatal lung disease, with a prognosis that can be worse than many forms of cancer [1, 2]. There have been a number of important advances and achievements in this field over the past 2 years, which have increased our understanding of how IPF can be managed and brought new hope for patients who have this devastating disease. Until recently, there were no pharmacological treatments approved for patients with IPF in Europe. A … ER -